Low RBM3 protein expression correlates with clinical stage, prognostic classification and increased risk of treatment failure in testicular non-seminomatous germ cell cancer.

by Sven-Erik Olofsson, Björn Nodin, Alexander Gaber, Jakob Eberhard, Mathias Uhlén, Karin Jirström, Mats Jerkeman
Published 2015-01-01